TABLE 2.
Demographic and clinical information of the 50 patients with angiocentric gliomas
| Demographic | |
|---|---|
| Median age at diagnosis (years [range]) | 13 [2‐83] |
| Sex | Male = 35, Female = 14, Not described = 1 |
| Clinical | |
| Seizure/epilepsy | 36/50 (72.0%) |
| Median length of seizure/epilepsy history (years [range])a | 2 [<1‐35] |
| Treatment strategy | |
| Surgery alone | 39/48 (81.3%) |
| Surgery and radiation | 1/48 (2.1%) |
| Surgery and chemotherapy | 2/48 (4.2%) |
| Chemotherapy alone | 3/48 (6.3%) |
| Chemotherapy and radiation | 1/48 (2.1%) |
| Follow‐up | 1/48 (2.1%) |
| Recurrence after complete resection | 2/29 (6.9%) |
| Patient status | Survive = 40/41 (97.6%), Death = 1/41 (2.4%) |
| Follow‐up duration (median [range]) (41 patients) | 16 months [2‐84] |
a
The length was calculated by subtracting the age of seizure/epilepsy onset from age at diagnosis. The length of the patients presenting with their first episode of seizure/epilepsy was calculated as zero (6 cases). Cases without a specific history length were excluded from the calculation (7 cases).